These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30513359)

  • 1. Allergic bronchopulmonary aspergillosis successfully treated with benralizumab.
    Soeda S; Kono Y; Tsuzuki R; Yamawaki S; Katsube O; To M; To Y
    J Allergy Clin Immunol Pract; 2019; 7(5):1633-1635. PubMed ID: 30513359
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment.
    Tomomatsu K; Sugino Y; Okada N; Tanaka J; Oguma T; Asano K
    Allergol Int; 2020 Oct; 69(4):636-638. PubMed ID: 32247541
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic bronchopulmonary aspergillosis and omalizumab.
    Tillie-Leblond I; Germaud P; Leroyer C; Tétu L; Girard F; Devouassoux G; Grignet JP; Prudhomme A; Dusser D; Wallaert B
    Allergy; 2011 Sep; 66(9):1254-6. PubMed ID: 21517902
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.
    Bernal-Rubio L; de-la-Hoz Caballer B; Almonacid-Sánchez C; González-de-Olano D
    J Investig Allergol Clin Immunol; 2020; 30(5):378-379. PubMed ID: 32376515
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
    Oda N; Miyahara N; Senoo S; Itano J; Taniguchi A; Morichika D; Fujii U; Maeda Y; Kiura K; Kanehiro A
    Allergol Int; 2018 Oct; 67(4):521-523. PubMed ID: 29665990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
    Delgado Pecellín I; Quintana Gallego E; Pedregal Solano C; Calero Acuña C
    Med Clin (Barc); 2015 Feb; 144(4):190-1. PubMed ID: 25015245
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic bronchopulmonary aspergillosis presumably unmasked by PD-1 inhibition.
    Donato AA; Krol R
    BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30765445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis.
    Tashiro H; Takahashi K; Kurihara Y; Sadamatsu H; Kimura S; Sueoka-Aragane N
    Allergol Int; 2021 Jan; 70(1):145-147. PubMed ID: 32917523
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of allergic bronchopulmonary aspergillosis treated with omalizumab.
    Sastre I; Blanco J; Mata H; García F
    J Investig Allergol Clin Immunol; 2012; 22(2):145-7. PubMed ID: 22533243
    [No Abstract]   [Full Text] [Related]  

  • 10. Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
    Evans MO; Morris MJ; Coop CA; Evans SE
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):250-1. PubMed ID: 26162570
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
    Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
    BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
    Wolf BL; Johnson A
    J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic granulomatosis with polyangiitis successfully treated with benralizumab.
    Chica-Guzmán MV; Morillo-Guerrero R; Carrón-Herrero A; González-de-Olano D; Almonacid-Sánchez C
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):228-230. PubMed ID: 32407950
    [No Abstract]   [Full Text] [Related]  

  • 15. Benralizumab as initial treatment for chronic eosinophilic pneumonia.
    Yazawa S; Toyoshima M; Koda K; Suda T
    Allergol Int; 2021 Jan; 70(1):140-142. PubMed ID: 32807690
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-IgE therapy for allergic bronchopulmonary aspergillosis.
    Homma T; Kurokawa M; Matsukura S; Yamaguchi M; Adachi M
    J Microbiol Immunol Infect; 2016 Jun; 49(3):459-63. PubMed ID: 24291616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab.
    Soeda S; To M; Kono Y; Yamawaki S; Tsuzuki R; Katsube O; Watanabe N; To Y
    Allergol Int; 2019 Jul; 68(3):377-379. PubMed ID: 30704844
    [No Abstract]   [Full Text] [Related]  

  • 18. Benralizumab in Real Life.
    Miralles López JC; Escudero Pastor AI; Carbonell Martínez A; Navarro Garrido C; Bonilla Pacheco Y; Petrik Petrik Y
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):87-88. PubMed ID: 32573458
    [No Abstract]   [Full Text] [Related]  

  • 19. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
    Tanou K; Zintzaras E; Kaditis AG
    Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who is the owner of this glove?
    Shteinshnaider M; Shpirer I; Sandbank J; Vasserman M; Cohen N
    Isr Med Assoc J; 2004 Jul; 6(7):440-1. PubMed ID: 15274541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.